University of California, Berkeley
Also known as: California Cancer Consortium | Lawrence Berkeley National Laboratory | Lawrence Livermore National Laboratory at University of California | UC Berkeley | UC Berkeley and NBER | University of California | University of California at Berkeley | University of California, Berkeley | University of California, Davis, Dermatology | University of California, Davis - M.I.N.D. Institute | University of California, San Francisco Memory and Aging Center | University of California, San Francisco, USA
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1977Last known activity
Dec 31, 2025
Timeline
1860s
- Jan 1, 1868
University of California, Berkeley— Founded
Drugs by trial phase (76 distinct, 57 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (24 own, 0 via acquisition)
Phase 1 (18 own, 0 via acquisition)
Other trials (19 own, 0 via acquisition)
Indications
Studied for
- Acute Lung Injury
- Amblyopia
- Bipolar Disorder
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Cardiovascular Diseases
- Communicable Diseases
- Coronary Disease
- Death, Sudden
- Death, Sudden, Cardiac
- Disease
- Heart Arrest
- Heart Diseases
- Hemoptysis
- HIV Infections
- Hypertension
- Infections
- Inflammation
- Kidney Neoplasms
- Leukemia
- Lung Diseases
- Lung Neoplasms
- Lymphoma
- Multiple Myeloma
- Multiple Organ Failure
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Myocardial Infarction
- Myocardial Ischemia
- Myopia
- Neoplasms
- Neoplasms, Plasma Cell
- Obesity
- Plasmacytoma
- Precancerous Conditions
- Preleukemia
- Psychotic Disorders
- Respiratory Distress Syndrome
- Respiratory Distress Syndrome, Newborn
- Respiratory Tract Infections
- Schizophrenia
- Stomach Neoplasms
- Syndrome
- Tobacco Use Disorder
- Ventricular Fibrillation
Recent trials (50)
- NCT07053917CollaboratorPhase 1Dec 31, 2025
- NCT06367738Lead sponsorPhase 1Apr 1, 2025
- NCT06558422CollaboratorPhase 1Dec 1, 2024
- NCT06192160OfficialPhase 2Oct 15, 2024
- NCT06354088CollaboratorPhase 1Apr 24, 2024
- NCT06348056Lead sponsorN/AJan 22, 2024
- NCT06029530CollaboratorPhase 1Jan 1, 2024
- NCT05729282CollaboratorPhase 1Aug 1, 2023
- NCT05705518Lead sponsorPhase 4Jan 30, 2023
- NCT05861076Overall official - principal investigatorN/AJan 3, 2023
- NCT05861076Lead sponsorN/AJan 3, 2023
- NCT06092515CollaboratorN/AJan 1, 2023
- NCT05549726CollaboratorPhase 4Nov 1, 2022
- NCT05549726Overall official - principal investigatorPhase 4Nov 1, 2022
- NCT05265546Lead sponsorPhase 1Oct 1, 2022
Details
- Founded
- Berkeley, CA, US Jan 1, 1868
- Last known activity
- Dec 31, 2025